Investment Rating - The investment rating for the company is "Accumulate" [6][19]. Core Views - The report emphasizes that the core subsidiary, Jinsai Pharmaceutical, is increasing its investment in research and sales, which is impacting short-term profitability. The focus is on the innovation pipeline data and business development transactions as catalysts for growth, maintaining the "Accumulate" rating [2][12]. Financial Summary - Total revenue for 2023 is projected at 14,566 million, with a year-on-year growth of 15.4%. However, a decline of 7.6% is expected in 2024, followed by a slight decrease of 0.3% in 2025, and a recovery with growth of 2.8% in 2026 and 2.7% in 2027 [4]. - Net profit attributable to the parent company is forecasted to be 4,532 million in 2023, with a significant drop of 43.0% to 2,583 million in 2024. The net profit is expected to further decline to 2,148 million in 2025, before recovering to 2,376 million in 2026 and 2,525 million in 2027 [4]. - Earnings per share (EPS) is projected to decrease from 11.11 yuan in 2023 to 5.26 yuan in 2025, with a gradual increase to 6.19 yuan by 2027 [4]. Market Data - The company's target price is set at 157.94 yuan, with the current price at 127.49 yuan [6][12]. - The market capitalization is reported at 52,008 million, with a 52-week price range of 78.90 to 128.00 yuan [7]. Investment Highlights - Jinsai Pharmaceutical, as a leader in the growth hormone industry, is expected to maintain its competitive edge despite a deteriorating competitive landscape for long-acting growth hormones. The company has five years of real-world data proving the safety of its long-acting products and has received approvals for three major indications [12]. - The report highlights the diversification of product revenue, with a focus on new key products such as Jinbeixin and Meishiya, which are expected to capture significant market potential [12]. - The company has a rich pipeline of research projects, with several candidates expected to submit IND applications in the second half of the year, indicating potential for international market expansion [12].

债券研究 /[Table_Date] 2025.09.08 慢牛延续，行情扩散 [Table_Authors] 顾一格(分析师) 转债事件点评 本报告导读： 投资要点： 虽然当前转债价格和估值仍处于历史高位，但在"慢牛"思维下，短期调整反而为 优质个券提供布局机会。 [Table_Report] 相关报告 债 券 事 件 点 评 美联储"转鸽"后，国内宽货币空间几何 2025.08.28 抢筹加速期，估值不言顶 2025.08.24 "此"宽货币，已非"彼"宽货币 2025.08.18 7 月金融数据全览 2025.08.15 抢筹行情延续，双击势能仍在 2025.08.09 证 券 研 究 报 告 研 究 请务必阅读正文之后的免责条款部分 可转债市场整体呈现先抑后扬的态势。中证转债指数全周上涨 0.61%，与此 前一周下跌 2.58%相比有所回暖，但同期中证 1000 指数下跌 2.59%，转债 表现整体强于正股。从结构看，低价转债和双低转债表现好于高价低溢价率 转债。周一转债继续相对正股超跌，转股溢价率进一步压缩，周二至周四正 股下跌期间，转债相对正股抗跌，周五随着正股反弹，转债大幅反弹，转债 等权指数涨 ...

Investment Rating - The report maintains a "Buy" rating for the company [6][10]. Core Views - The company's revenue for the first half of 2025 decreased by 8% year-on-year, primarily due to a decline in income from BOT water service construction projects. However, significant savings in financial expenses and effective cost control were noted [2][10]. - The report forecasts net profits for 2025-2027 to be 1.522 billion, 1.603 billion, and 1.672 billion RMB respectively, with corresponding EPS of 0.15, 0.16, and 0.17 RMB [10][11]. Financial Summary - Total revenue (million RMB): - 2023A: 24,519 - 2024A: 24,270 - 2025E: 24,257 - 2026E: 25,003 - 2027E: 26,122 - Net profit (million RMB): - 2023A: 1,896 - 2024A: 1,678 - 2025E: 1,522 - 2026E: 1,603 - 2027E: 1,672 - The report indicates a gross profit margin improvement of 1.98 percentage points to 39.95% due to an increase in high-margin water treatment service revenue [4][10]. Revenue Composition - Revenue contributions from various segments for the first half of 2025: - Sewage treatment: 43% - Water supply: 14% - Urban resource services: 29% - Construction and technical service equipment sales: 14% [10]. Cost Management - Management expenses decreased by 8% to 1.157 billion RMB, and financial expenses reduced by 31% to 0.958 billion RMB, reflecting effective cost control measures [10][11]. Dividend and Capital Expenditure - The company plans to distribute an interim dividend of 0.0735 HKD per share, a 5% increase year-on-year. Capital expenditure for the first half of 2025 decreased by 40% to 0.943 billion RMB [10][11].

Investment Rating - The report maintains a "Buy" rating for the company [4][11]. Core Views - The company is expected to achieve stable revenue growth and maintain profitability, with a target price raised to 26.09 CNY from the previous 22.71 CNY [11]. - The company has a robust order backlog in marine projects and is actively expanding its special optical fiber business [11]. Financial Summary - Total revenue is projected to grow from 47,622 million CNY in 2023 to 96,245 million CNY by 2027, reflecting a compound annual growth rate (CAGR) of approximately 16.4% [3][12]. - Net profit attributable to the parent company is expected to increase from 2,154 million CNY in 2023 to 4,773 million CNY in 2027, with a CAGR of about 20.7% [3][12]. - Earnings per share (EPS) is forecasted to rise from 0.87 CNY in 2023 to 1.94 CNY in 2027 [3][12]. - The return on equity (ROE) is anticipated to improve from 8.4% in 2023 to 12.1% in 2027 [3][12]. Market Data - The company's market capitalization is approximately 49,581 million CNY, with a total share capital of 2,467 million shares [5]. - The stock has traded within a range of 14.16 CNY to 20.90 CNY over the past 52 weeks [5]. Order Backlog and Business Expansion - The company currently holds marine power, marine engineering, and land cable orders totaling around 20 billion CNY, with marine communication-related orders amounting to 7.5 billion CNY [11]. - The acquisition of the German company j-fiber, which has nearly 40 years of experience in special optical fiber production, is expected to enhance the company's capabilities [11].

Investment Rating - The report assigns an "Overweight" rating for the humanoid robot industry, indicating a potential increase of over 15% relative to the CSI 300 index [10]. Core Insights - The recent procurement contract worth 250 million yuan for humanoid robot products and solutions by UBTECH is a significant milestone, marking the largest contract in the global humanoid robot sector to date. This event signifies the early stages of commercialization in the humanoid robot industry [2][4]. - The report emphasizes the importance of focusing on quality companies within the humanoid robot supply chain that possess customer orders and scalable production capabilities. Recommended companies include Meih Lake Co., New Spring Co., Ningbo Huaxiang, Top Group, Zhaomin Technology, and Joyson Electronics [4][5]. Summary by Sections Recent Developments - UBTECH has secured a 250 million yuan order for humanoid robots, specifically for the Walker S2 model, which features an autonomous hot-swappable battery system. The delivery of this contract is set to commence within the year [4]. - Tesla has introduced its fourth phase of the "Secret Master Plan," focusing on sustainable development and the integration of hardware and software to create a safer and cleaner world. This includes the development of fully autonomous humanoid robots aimed at redefining labor and enhancing human productivity [4]. Financial Projections - The report provides earnings per share (EPS) estimates for several companies in the humanoid robot sector for the years 2025 to 2027, along with their price-to-earnings (PE) ratios. For instance, Meih Lake Co. is projected to have an EPS of 0.75 yuan in 2025 with a PE ratio of 50, while Ningbo Huaxiang is expected to have an EPS of 0.55 yuan and a PE of 55 [5].

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of 19.20 CNY [6][13] Core Views - The company is currently facing short-term performance pressure due to the downturn in the photovoltaic industry, but it has a clear long-term growth momentum driven by technological advancements and a recovering photovoltaic glass market [2][13] - The company's market share in photovoltaic glass is approximately 30%, and it is focusing on high-transparency, ultra-thin, and high-efficiency products to enhance its competitive edge [13] Financial Summary - Total revenue for 2023 is projected at 21,524 million CNY, with a decrease to 15,050 million CNY in 2025, reflecting a decline of 19.4% [4] - Net profit attributable to shareholders is expected to drop from 2,760 million CNY in 2023 to 572 million CNY in 2025, a decrease of 43.2% [4] - Earnings per share (EPS) is forecasted to be 1.18 CNY in 2023, dropping to 0.24 CNY in 2025, before recovering to 0.78 CNY by 2027 [4][14] Market and Industry Analysis - The photovoltaic glass market is experiencing a supply-demand imbalance, leading to significant price declines in the first half of 2025, which has adversely affected the company's revenue and net profit [13] - In August, the photovoltaic glass industry began to show signs of recovery, with prices improving and inventory levels decreasing, which is expected to support profitability moving forward [13] Future Outlook - The company is projected to see a gradual recovery in revenue and profit margins from 2026 onwards, with expected revenues of 20,017 million CNY in 2026 and 23,020 million CNY in 2027 [4][14] - The report anticipates that the company's technological innovations will continue to drive its market position and profitability in the long term [13]

Investment Rating - The report assigns an "Accumulate" rating for the livestock industry, specifically the pig farming sector [5]. Core Insights - The report highlights profit growth, reduced debt, and increased dividends in the livestock sector, maintaining a positive outlook for the pig farming industry [3][4]. Summary by Sections Profit and Loss Statement: Revenue and Profit Growth - In Q2 2025, the average pig price was 14.59 CNY/kg, down 10.82% from 16.36 CNY/kg in the same period of 2024. Despite this, sales volume increased, indicating a volume-driven revenue impact [8]. - The total operating revenue for Q2 2025 reached 120.56 billion CNY, reflecting a year-on-year increase of 15.20% and a quarter-on-quarter increase of 9.85%. Improved breeding efficiency and survival rates contributed to a decrease in breeding costs, leading to profit enhancement. The net profit attributable to shareholders for Q2 2025 was 8.715 billion CNY, up 23.4% year-on-year and an increase of 785 million CNY from the previous quarter [9]. Balance Sheet: Debt Reduction and Slow Capital Expenditure - The total fixed assets reported were 232.541 billion CNY, a year-on-year increase of 0.97%, but a slight quarter-on-quarter decrease of 800 million CNY. Capital expenditure was 6.143 billion CNY, up 31.75% year-on-year but down approximately 700 million CNY quarter-on-quarter. The construction in progress decreased by 39.65% year-on-year [10]. - The average debt-to-asset ratio fell to 56.27% in Q2, a decrease of about 2 percentage points from Q1, primarily due to ongoing debt repayments. Short-term borrowings decreased to 74.143 billion CNY, down 11.03% year-on-year, while long-term borrowings fell to 39.529 billion CNY, a year-on-year decline of 28% [15]. Cash Flow Statement: Improvement in Cash Flow - The net cash flow from operating activities for Q2 2025 was 20.194 billion CNY, an increase of 6.616 billion CNY quarter-on-quarter, indicating a gradual improvement in cash flow alongside a reduction in debt ratio [20]. Dividend Growth - The report notes that with improved cash flow, reduced debt ratios, and favorable breeding profits, companies such as Muyuan Foods, Shennong Group, and Jingji Zhino are distributing dividends. The expectation is that as borrowing and debt ratios continue to decline, more companies in the industry will increase their dividends [24]. Recommended Stocks - The report recommends the following stocks in the livestock sector: - Muyuan Foods (Stock Code: 002714.SZ) - Wens Foodstuff Group (Stock Code: 300498.SZ) - Tian Kang Biological (Stock Code: 002100.SZ) - Shennong Group (Stock Code: 605296.SH) - Juxing Agriculture (Stock Code: 603477.SH) [26][27].

Investment Rating - The investment rating for the company is "Accumulate" [4][17]. Core Views - The report highlights that the company has shown strong performance in Q2 2025, with significant growth in its refrigeration components and gradual improvement in its automotive parts business, leading to a noticeable enhancement in profitability [1][10]. - The earnings forecast has been raised, with expected net profits for 2025-2027 at 38.56 billion, 45.14 billion, and 52.01 billion respectively, reflecting a year-on-year growth of 24%, 17%, and 15% [10][11]. - The target price has been adjusted to 38.64 yuan based on a 42x PE ratio for 2025, considering the average valuation of key components in the new energy vehicle and robotics sectors [10][11]. Financial Summary - The company reported total revenue of 162.63 billion yuan for H1 2025, a year-on-year increase of 18.91%, with a net profit of 21.1 billion yuan, up 39.31% [10][11]. - The revenue from the refrigeration components business reached 103.89 billion yuan, growing by 25% year-on-year, while the automotive parts business generated 58.74 billion yuan, a 9% increase [10][11]. - The gross margin for H1 2025 was 28.12%, with a net margin of 13.15%, showing improvements from the previous year [10][11]. Market Data - The company's market capitalization is approximately 134.223 billion yuan, with a total share capital of 4.209 billion shares [5]. - The stock price has fluctuated between 16.75 and 35.32 yuan over the past 52 weeks [5]. - The company has a net asset value per share of 6.91 yuan, with a price-to-book ratio of 4.6 [6].

Economic Trends - Indonesia's exports grew by 11.3% in July, maintaining high growth levels, while imports fell by -5.3%, resulting in a trade surplus of over $4.1 billion[7] - Thailand's retail sales averaged a growth rate of 31.3% over the past five months, despite a slight decline in production in July[12] - Vietnam attracted $11.72 billion in foreign direct investment (FDI) in the first half of the year, marking an 8.1% increase, the highest level for the same period in five years[22] - Malaysia's exports rebounded in July with a growth rate of 6.8%, significantly improving from the previous two months[23] Policy Developments - Indonesia launched the world's largest village-level solar energy project, aiming for a total installed capacity of 100GW over five years[28] - Thailand relaxed electric vehicle policy conditions, leading to a 52% year-on-year increase in new electric vehicle registrations in the first half of 2025[29] - Vietnam abolished its long-standing gold monopoly, allowing commercial banks and qualified enterprises to trade gold freely[31] - Malaysia introduced its first AI processing chip, the MARS1000, to compete in the global AI component market[32] Geopolitical Relations - Thailand's trade promotion department implemented measures to counteract the 19% tariffs imposed by the U.S., including low-interest loans and market expansion initiatives[33] Risk Factors - The report highlights geopolitical risks and economic downturn risks as potential challenges for the Southeast Asian markets[34]

Investment Rating - The investment rating for the company is "Accumulate" [5] Core Views - The company's performance in the first half of 2025 met expectations, demonstrating resilience in profitability despite the downturn in the ferroalloy and caustic soda PVC industries. The report anticipates limited further decline in the industry, with the company's performance gradually stabilizing [2][11] Financial Summary - Total revenue for 2025 is projected at 27,006 million, a decrease of 4.9% from 2024 - Net profit attributable to shareholders is expected to be 2,054 million, reflecting an increase of 11.2% from 2024 - Earnings per share (EPS) is forecasted to be 0.73 yuan for 2025, with a gradual increase to 0.89 yuan by 2027 - The return on equity (ROE) is expected to improve from 8.8% in 2024 to 11.1% in 2027 [4][12] Industry Performance - The ferroalloy segment showed stable operations, with silicon iron and silicon manganese production at 79.28 and 9.58 million tons respectively in the first half of 2025 - The PVC and caustic soda segments experienced production growth, with PVC output at 54.33 million tons and caustic soda at 36.32 million tons, reflecting increases of 2.54 and 2.11 million tons respectively [11][12] Valuation - The target price for the company has been raised to 13.14 yuan, based on a price-to-earnings (PE) ratio of 18 times for 2025, which is slightly below the industry average of 21.33 times [11][13]